Advertisement
Opthea Limited

Opthea Limited (OPT) Stock Overview

Explore Opthea Limited’s financial performance, market position, analyst ratings, and future outlook.

OPTNASDAQ
HealthcareBiotechnology
$3.41
$0.05(1.49%)
U.S. Market is Open · 14:06
Advertisement

Opthea Limited (OPT)

Meyka AI Score

Z

Key Financials

Market Cap4.2B
P/E Ratio-3.20
EPS (TTM)$-2.25
ROE1.09%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

OPT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Opthea Limited (OPT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.20 and a market capitalization of 4.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-38.67%
6-Month Change
-21.43%
Year-to-Date (YTD) Change
-7.59%
1-Year Change
3.65%
3-Year Change
-41.81%
5-Year Change
-72.28%
All-Time (Max) Change
-72.28%

Contact Information

61 3 9826 0399
650 Chapel Street, South Yarra, VIC, 3141

Company Facts

330 Employees
IPO DateOct 16, 2020
CountryAU

Frequently Asked Questions